Humana Inc. $HUM Shares Purchased by IFP Advisors Inc

IFP Advisors Inc boosted its position in Humana Inc. (NYSE:HUM) by 45.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 799 shares of the insurance provider’s stock after acquiring an additional 250 shares during the quarter. IFP Advisors Inc’s holdings in Humana were worth $195,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HUM. Revolve Wealth Partners LLC acquired a new position in Humana in the fourth quarter valued at $202,000. GAMMA Investing LLC boosted its holdings in Humana by 54.9% in the first quarter. GAMMA Investing LLC now owns 2,952 shares of the insurance provider’s stock valued at $781,000 after acquiring an additional 1,046 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in Humana by 144.4% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 15,734 shares of the insurance provider’s stock valued at $4,163,000 after acquiring an additional 9,296 shares during the last quarter. Exchange Traded Concepts LLC boosted its holdings in Humana by 8.0% in the first quarter. Exchange Traded Concepts LLC now owns 1,286 shares of the insurance provider’s stock valued at $340,000 after acquiring an additional 95 shares during the last quarter. Finally, Janney Montgomery Scott LLC acquired a new position in Humana in the first quarter valued at $1,309,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on HUM. Sanford C. Bernstein lifted their target price on Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a report on Friday, September 5th. Bank of America boosted their price objective on Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research note on Friday, October 10th. Royal Bank Of Canada boosted their price objective on Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a research note on Thursday, August 21st. Wells Fargo & Company boosted their price objective on Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Finally, Morgan Stanley reduced their price objective on Humana from $290.00 to $277.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 31st. Eight equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average price target of $297.58.

Humana Trading Up 2.9%

NYSE:HUM opened at $275.00 on Friday. The business’s 50-day simple moving average is $280.54 and its 200 day simple moving average is $258.23. Humana Inc. has a one year low of $206.87 and a one year high of $315.35. The stock has a market cap of $33.07 billion, a price-to-earnings ratio of 21.11, a price-to-earnings-growth ratio of 1.56 and a beta of 0.42. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. During the same quarter in the previous year, the company earned $6.96 EPS. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.3%. Humana’s dividend payout ratio is presently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.